Growth Metrics

Eli Lilly (LLY) Tax Rate Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -374.00
Dec 31, 2025 723.00
Sep 30, 2025 -1,610.00
Jun 30, 2025 82.00
Mar 31, 2025 861.00
Dec 31, 2024 -24.00
Sep 30, 2024 -7,452.00
Jun 30, 2024 5.00
Mar 31, 2024 -52.00
Dec 31, 2023 514.00
Sep 30, 2023 10,617.00
Jun 30, 2023 291.00
Mar 31, 2023 474.00
Dec 31, 2022 139.00
Sep 30, 2022 -359.00
Jun 30, 2022 -9.00
Mar 31, 2022 -86.00
Dec 31, 2021 -808.00
Sep 30, 2021 -506.00
Jun 30, 2021 -132.00
Mar 31, 2021 -510.00
Dec 31, 2020 420.00
Sep 30, 2020 511.00
Jun 30, 2020 463.00
Mar 31, 2020 -995.00
Dec 31, 2019 3,044.00
Sep 30, 2019 -765.00
Jun 30, 2019 -64,593.00
Mar 31, 2019 872.00
Dec 31, 2018 -51,616.00
Sep 30, 2018 1,237.00
Jun 30, 2018 63,536.00
Mar 31, 2018 -26,651.00
Dec 31, 2017 48,231.00
Sep 30, 2017 -1,377.00
Jun 30, 2017 -80.00
Mar 31, 2017 25,869.00
Dec 31, 2016 2,108.00
Sep 30, 2016 -383.00
Jun 30, 2016 923.00
Mar 31, 2016 805.00
Dec 31, 2015 -2,417.00
Sep 30, 2015 5.00
Jun 30, 2015 -1,039.00
Mar 31, 2015 -398.00
Dec 31, 2014 -348.00
Sep 30, 2014 313.00
Jun 30, 2014 162.00
Mar 31, 2014 -237.00
Dec 31, 2013 175.00
Sep 30, 2013 -873.00
Jun 30, 2013 -173.00
Mar 31, 2013 -362.00
Dec 31, 2012 67.00
Sep 30, 2012 1,152.00
Jun 30, 2012 29.00
Mar 31, 2012 717.00
Dec 31, 2011 60.00
Sep 30, 2011 -433.00
Jun 30, 2011 -51.00
Mar 31, 2011 -980.00
Dec 31, 2010 -248.00
Sep 30, 2010 1,010.00
Jun 30, 2010 125.00
Mar 31, 2010 492.00